|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/496 | |
| A61K 31/365 | |||
| A61K 31/137 | |||
| A61K 31/34 | |||
| A61P 3/04 |
| (11) | Patento numeris | 1912650 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06764270.2 |
| Europos patento paraiškos padavimo data | 2006-07-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-04-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-08-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2006/064825 |
| Data | 2006-07-31 |
| (87) | Numeris | WO 2007/014929 |
| Data | 2007-02-08 |
| (30) | Numeris | Data | Šalis |
| 05016867 | 2005-08-03 | EP |
| (72) |
CECI, Angelo, DE
SCHINDLER, Marcus, DE
|
| (73) |
Sprout Pharmaceuticals, Inc.,
400 Somerset Corporate Blvd., Bridgewater, NJ 08807,
US
|
| (54) | USE OF FLIBANSERIN IN THE TREATMENT OF OBESITY |
| USE OF FLIBANSERIN IN THE TREATMENT OF OBESITY |